Tagged with bioMérieux

China Vincent Chan, VP and GM of bioMérieux Greater China, shares insights into how the microbiology diagnostics company’s presence has evolved in China over the course of 30 years to today serve some 4,000 hospitals across the country. He walks us through the government measures that have prioritized microbiology testing to…

France A roundup of the top stories coming out of France’s pharma industry, including Sanofi’s consumer health unit spinout and EUR 40 million investment in antibody bioproduction; the French govenment’s unprecedented deal with Upsa; the Health Minister’s plans to lower the national social security system’s reimbursement of drugs; Servier’s newfound willingness…

France At the 13th annual meeting of French life sciences think tank, G5 Santé – which represents the leaders of eight major French health and life sciences companies, including bioMérieux, Sanofi, Ipsen, and Pierre Fabre – arguments were made for increasing efficiency in a healthcare system that is “on its last…

Saudi Arabia Fadi Ghanayem, Managing Director for Saudi Arabia and Caucasus, Central Asia, Iran and Mongolia (CCAIM) at French diagnostics firm BioMérieux discusses the remarkable growth he has witnessed in Saudi Arabia thanks to the government’s push to improve healthcare and prevention in recent years.  In addition, he outlines the opportunities that…

France With revenues projected to reach USD 27.01 billion in 2024, France’s pharma market is ranked fifth globally. Home to a number of well-established local pharma players and a sought-after destination for international investments, France is looking to boost innovation, attracting the largest number of R&D centres in Europe in 2022,…

France France’s life sciences industry is falling behind its European neighbours, its growth deeply hampered, the French life sciences think tank G5 Santé claims, by abusive paybacks. While the government has demonstrated its willingness to take steps towards levelling its pricing barometers and in so doing tackle medicine shortages and build…

France Exor, led by Fiat brand heirs the Agnelli family, has signed a partnership agreement for an investment of EUR 833 million in the also family-owned French holding, Institut Mérieux, known for its diagnostic arm, BioMérieux. Under the new partnership, Exor will acquire a 10% shareholding in Institut Mérieux by way…

Thailand Brijesh Sawlani, general manager for North ASEAN Thailand, Myanmar and Indochina at bioMérieux, discusses current opportunities for the Thai affiliate, the competitive landscape in Thailand, his key strategic objective to foster long-term growth, and the innovative solutions that bioMérieux is bringing to the country.   At bioMérieux, we keep in…

Algeria Multinational pharmaceutical companies are increasingly choosing Algeria as a base for their regional headquarters, despite the complexities of the local market. The representatives of Lilly, bioMérieux and Abbott in Algeria tell us why. As geographically the largest country in Africa, Algeria stands out, as does its universal healthcare system which bears…

Algeria Nadia Oka-Bousbia of bioMérieux Algeria discusses the affiliate’s important role within Algeria’s fight against infectious diseases and the training of health managers, difficulties surrounding import restrictions, and the company’s constantly-evolving strategy for the future.   These are exciting times for bioMérieux locally. We understand that earlier this year, your global…

Colombia Rocío Mendez, country manager at bioMérieux Colombia, speaks about the many talents that make up the Colombian affiliate and explains how the company brings life-saving and innovative solutions to a thriving Colombian healthcare sector. This is your first time as a country manager. Why did the global management board think…

Switzerland The General Manager of bioMérieux Switzerland and Austria highlights the significance of Switzerland for the company’s regional cluster and furthermore explains how Switzerland contributes to the global development of the company. Could you please introduce yourself and bioMérieux’s organization in Switzerland and Austria? “Our overall mission is naturally to improve…